Michael Martin Breen Gt Biopharma, Inc. (GTBP) insider trading activity
Michael Martin Breen is Executive Chairman/Interim CEO of GT Biopharma, Inc.. Currently has a direct ownership of 856,218 shares of GTBP, which is worth approximately $2.62 Million. The most recent transaction as insider was on Aug 11, 2023, when has been sold 200,000 shares (Common Stock) at a price of $0.29 per share, resulting in proceeds of $57,999. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
856K
0%
3M change
0%
12M change
Total Value Held
$2.62 Million
Michael Martin Breen Transaction History
Also insider at
MMB
Michael Martin Breen
Executive Chairman/Interim CEO
Brisbane, CA